| scholarly article | Q13442814 |
| P2093 | author name string | T Clark Gamblin | |
| Kiran K Turaga | |||
| Sam Pappas | |||
| P2860 | cites work | Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma | Q43853697 |
| Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding | Q44388072 | ||
| Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence | Q49118164 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer | Q80033156 | ||
| Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy | Q83903423 | ||
| Cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: Why haven't we reached the promised land? | Q85097732 | ||
| The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial | Q24629295 | ||
| Cancer statistics, 2006 | Q29615133 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer | Q33341957 | ||
| New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? | Q33992651 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial | Q34928467 | ||
| Gastric cancer epidemiology and risk factors | Q35067625 | ||
| A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. | Q36892244 | ||
| Surgical treatment for peritoneal carcinomatosis from gastric cancer | Q37798985 | ||
| Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial | Q40332575 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 405652 | |
| P577 | publication date | 2012-06-20 | |
| P1433 | published in | International Journal of Surgical Oncology | Q26842828 |
| P1476 | title | Surgical treatment of peritoneal carcinomatosis from gastric cancer | |
| P478 | volume | 2012 |
| Q50761729 | Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis. |
| Q91935621 | MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription |
| Q54977995 | PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K/AKT signaling pathway in vitro and in vivo. |
| Q37255490 | PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. |
Search more.